Download - Max International Virtual Office

PRODuCT
“dr. Herb Nagasawa’s findings were published in prestigious, international, peer-reviewed, scientific journals,” Scott Momii
said. “As far as I was concerned his science was rock-solid. dr. Nagasawa also had the foresight to apply for patents for his
technology, so it could be proprietary to a company.”
Keller/Nagasawa Synergy
Scott Nagasawa said there are over 75,000 published articles on glutathione. Yet with all of the research and literature there
were very few researchers looking for better methods to increase the production of glutathione in the body.
“dr. Keller’s scientific breakthrough is really in his unique formulation,” dr. Scott Nagasawa said. “It not only provides the
building blocks for glutathione but also key nutrients that support their absorption as well as their function and other key
ingredients that support glutathione itself. As you know, the unique formula has been proven in a clinical trial to increase
glutathione levels.”
dr. Scott Nagasawa said that as a medicinal chemist dr. Herb Nagasawa’s approach was a solution through chemistry.
“Herb synthesized and screened in the laboratory dozens and dozens of compounds for toxicity and their oral activity,”
Scott Nagasawa said. “Those that showed no toxicity and highly oral activity were further screened for their delivery
characteristics. The technology utilized by Herb is often seen in the pharmaceutical industry where they have identified an
active compound when given intraveneously but when given orally it loses some or all of its activity.. Herb’s technology—
what he is an expert at— takes the active compound and converts it into what we call a precursor compound, that can get
through the digestive tract and into the cell. From there a metabolic process occurs, releasing cysteine which is incorporated
into glutathione synthesis.”
Momii said CellGevity considered many different companies before coming to Max. After much due diligence their research
revealed Max was a perfect fit. Max shared CellGevity’s vision of being a leader in glutathione technology.
“Max is dedicated to glutathione and understands the glutathione market,” Momii said. “Max has a seasoned leadership
team with Co-founders having a commitment and belief in glutathione. We could not have found a better partner. For us it
was a hand-in-glove fit and we are excited to be part of the Max family.”
“The overwhelming question is the synergy between the quests of dr. Keller and dr. Nagasawa and the collective visions of
future research and development for Max International and CellGevity,” dave said. “Our commitment is to make every effort
to honor what dr. Keller initiated while implementing dr. Nagasawa’s technology and research over the last 40 years into the
space of Max International. We will follow through on that commitment and take that technology to the world.”
10